Par Pharmaceutical Companies, Inc. today announced the resignation of Gerard A. Martino, executive vice president and chief operating officer.
Earlier today, Par announced a resizing of its generic business as part of an ongoing strategic assessment of the overall business. Mr. Martino will stay on through the transition.
Patrick G. LePore, Par's chairman, chief executive officer and president said, "All of us at Par are grateful to Jerry for the many contributions he has made to the Company. Jerry led us through a very difficult time during our financial restatement and engineered significant improvement to Par's systems, operations and business practices. We wish him success in his future endeavors."
About Par
Par Pharmaceutical Companies, Inc. develops, manufactures and markets generic drugs and innovative branded pharmaceuticals for specialty markets.
Source: Par Pharmaceutical Companies, Inc.
Earlier today, Par announced a resizing of its generic business as part of an ongoing strategic assessment of the overall business. Mr. Martino will stay on through the transition.
Patrick G. LePore, Par's chairman, chief executive officer and president said, "All of us at Par are grateful to Jerry for the many contributions he has made to the Company. Jerry led us through a very difficult time during our financial restatement and engineered significant improvement to Par's systems, operations and business practices. We wish him success in his future endeavors."
About Par
Par Pharmaceutical Companies, Inc. develops, manufactures and markets generic drugs and innovative branded pharmaceuticals for specialty markets.
Source: Par Pharmaceutical Companies, Inc.
0 comments:
Post a Comment